iShares Nasdaq Biotechnology Index (ETF) (IBB) Is at a Crossroads

The iShares Nasdaq Biotechnology ETF (IBB) is showing relative strength, but the IBB ETF must overcome this hurdle to continue rallying. More 

Study Free Profits From iShares Nasdaq Biotechnology Index (ETF) (IBB) Stock

The meme that biotechs are untouchable for as long as Trump is tweeting about price wars is ebbing. Go long IBB with room for error. More 

Catch Valeant Pharmaceuticals Intl Inc (VRX) Stock for Free

Valeant Pharmaceuticals (VRX) has no shortage of haters, but don't be shy on red days. Go long VRX stock with a huge buffer zone! More 

Get in Biogen Inc (BIIB) Stock Before It Breaks Out

Biogen (BIIB) hasn't had much love from Wall Street this year, but its fundamentals are strong. Go long this popularity bottom in BIIB stock. More 

3 Healthcare Tickers That Will Return Profits in 3 Months

Not many experts dare fight Trump. Consequently, pharma stocks have been lidded. Try trades in GILD, BIIB and IBB while they are cheap. More 

Why Valeant Pharmaceuticals Intl Inc (VRX) Stock Will Finally Stabilize

Valeant Pharmaceuticals (VRX) is finally getting its house in order. Don't expect VRX stock to explode, but it will get a lift. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB) Shows Signs of Hope

The iShares Nasdaq Biotechnology ETF (IBB) gave off an initial signal of hope for a better rally in biotech stocks. Here's how to handle IBB. More